Pharmacists provide patient value in team-based care

With inhaler in hand, Dr. Cheng Yuet went over every detail to make sure the patient understood how the drug would control their COPD symptoms. Dr. Yuet is proving what a difference it makes when pharmacists are integrated into the health care team. As part of an innovative model being used at UNT Health Science Center, Dr. Yuet and three other pharmacists manage the care of patients with chronic diseases such as asthma, diabetes and hypertension.

"Our scope is pretty broad, which is unique in pharmacy," Dr. Yuet said. "As part of the health care team, our pharmacists can prescribe, change and refill medications; order laboratory tests; and schedule in-person or telephone visits for chronic disease state management."

Many patients are unfamiliar with seeing a pharmacist in this role, Dr. Yuet said.

"It is important for patients to have awareness of how a pharmacist could help them reach their treatment goals alongside their physician or advanced practice nursing providers," she said.

The model has been shown to improve outcomes for patients whose chronic diseases make care complex. Patients who are referred to pharmacist visits might take more than a dozen medications daily. Success has also been realized in terms of quality, collaboration and financial sustainability.

The Pharmacist-Led Chronic Care Management Services model being used at UNTHSC is featured in the September issue of the Annals of Family Medicine, said Dr. Yuet, the corresponding author of the article.

The approach also has won recognition from the Texas Society of Health-System Pharmacists, which presented the Innovative Collaborative Practice Award to the UNT Health Clinical Practice Group in April.

The service is believed to be the most expansive collaborative agreement in the state. The broad scope allows pharmacists to provide comprehensive medication management to virtually any patient in the practice independently.

Chronic diseases, like diabetes, pose a significant challenge for both the patient and the physician, said Randy Martin, PharmD, Associate Dean for Clinical Affairs and Associate Professor of Pharmacotherapy.

"Patients find themselves keeping track of multiple medications and seeing an array of providers," he said. "For physicians, there's a lot going on with these patients. ?This is where pharmacist-led chronic care management comes in."

As the medication expert, the pharmacist can streamline the patient's medication regimen, order labs, and provide important education on medications and lifestyle modifications.

Four pharmacists and 48 physicians work in collaboration to provide primary and specialty care at UNTHSC clinics.

The model demonstrates a revenue-generating, quality-focused approach that also helps to reduce costs at the institution, Dr. Yuet said. It was designed to generate revenue for the practice and offset the cost to incorporate a clinical pharmacist into the interprofessional health care team.

The approach benefits patients and health care.

"When we integrated pharmacists into the practice two years ago, we were passionate about giving patients access to a pharmacist in the clinic in a sustainable way," Dr. Martin said. "Chronic care management enhances patients' access to health care in a way that is complementary to their in-clinic visits."

Wei C Yuet, Jessica Gardea, Didi Ebert, Randy D Martin.
Pharmacist-Led Chronic Care Management Services.
Ann Fam Med September/October 2019 vol. 17 no. 5 465. doi: 10.1370/afm.2440.

Most Popular Now

AstraZeneca amends collaboration with Ironwood for…

AstraZeneca has amended its collaboration agreement with Ironwood Pharmaceuticals, Inc. (Ironwood) in China mainland, China Hong Kong and China Macau for Linzess (linaclo...

Cause of antibiotic resistance identified

Scientists have confirmed for the first time that bacteria can change form to avoid being detected by antibiotics in the human body. Studying samples from elderly patient...

Bayer, Brigham and Women’s Hospital, and Massachus…

Bayer and Partners HealthCare's founding members Brigham and Women's Hospital (BWH) and Massachusetts General Hospital (MGH) today announced the launch of a joint lab to ...

FDA grants Fast Track designation for Farxiga in h…

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of Farxiga (dapagliflozin) to reduce the risk ...

Amgen announces positive results from two Phase 3 …

Amgen (NASDAQ:AMGN) today announced that the results of a prespecified interim analysis of an open-label, randomized, controlled global multicenter Phase 3 trial (2012021...

Brilinta monotherapy in high-bleeding risk patient…

New data from TWILIGHT, a Phase IV independent trial (funded by AstraZeneca), showed that in patients at high-bleeding risk who underwent PCI and completed 3 months of du...

Gene-targeted cancer drugs, slow release overcome …

Biomedical engineers at Duke University have developed a method to address failures in a promising anti-cancer drug, bringing together tools from genome engineering, prot...

Educational campaign helps teens and their caregiv…

Teenagers face many challenges, and growing up with a chronic skin disease called atopic dermatitis (AD) can impact the ups and downs and transitions to young adulthood. ...

Study points to new drug target in fight against c…

Researchers have identified a potential new drug target in the fight against cancer. In a study this week in the Proceedings of the National Academy of Sciences, an inter...

AstraZeneca divests rights for Losec to Cheplaphar…

AstraZeneca has agreed to sell the global commercial rights, excluding China, Japan, the US and Mexico, for Losec (omeprazole) and associated brands to Cheplapharm Arznei...

Cheaper drug just as effective protecting heart in…

A new clinical trial conducted at The Ohio State University Wexner Medical Center found a cost-effective generic medication works just as well as a more expensive drug in...

Dengue virus becoming resistant to vaccines and th…

Researchers from Duke-NUS Medical School (DukeNUS), in collaboration with the Agency for Science, Technology and Research (A*STAR)'s Bioinformatics Institute (BII), and t...